Prevention of recurrent attacks

  • Angelo Taranta
  • Milton Markowitz


Prophylaxis of recurrences is the finest achievement of medicine in rheumatic fever. It is markedly effective and, in fact, it practically eliminates recurrences if injectable benzathine penicillin G is used. However, a great deal of patience, perseverance, and persuasiveness are required on the part of the health personnel involved. The success of secondary prophylaxis is way out of proportion to the numerical reduction of rheumatic fever attacks, because recurrences cause a disproportionate number of deaths and disabilities. Actually, the change in morbidity and mortality of the disease in the Western world is largely due to the reduction of recurrences.


Infective Endocarditis Rheumatic Fever Rheumatic Heart Disease Streptococcal Infection Acute Rheumatic Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Strasser, T. et al. (1981). Report of a WHO international cooperative project. Bull. WHO, 59, 285PubMedGoogle Scholar
  2. 2.
    Lue, H. C. et al. (1983). Clinical and epidemiological features of rheumatic fever and rheumatic heart disease in Taiwan and the Far East. Indian Heart J., 35, 139PubMedGoogle Scholar
  3. 3.
    Wood, H. F. et al. (1964). Rheumatic fever in children and adolescents. III. Comparative effectiveness of three prophylactic regimens in preventing streptococcal infections and rheumatic recurrences. Ann. Intern. Med., 60, (Suppl. 5), 31Google Scholar
  4. 4.
    Sanyal, S. K. et al. (1982). Sequelae of the initial attack of acute rheumatic fever in children from North India. Circulation, 65, 375PubMedCrossRefGoogle Scholar
  5. 5.
    Lue, H. C. et al. (1979). The natural history of rheumatic fever and rheumatic heart disease in the Orient. Jpn Heart J., 20, 237PubMedCrossRefGoogle Scholar
  6. 6.
    Saran, R. K. et al. (1985). Is monthly injection of benzathine penicillin adequate for rheumatic fever prevention in our country? J. Assoc. Physicians India, 33, 641PubMedGoogle Scholar
  7. 7.
    Lue, H. C. et al. (1986). Rheumatic fever recurrences: Controlled study of 3-week versus 4-week benzathine penicillin prevention programs. J. Pediatr., 108, 299PubMedCrossRefGoogle Scholar
  8. 8.
    Lade, R. I. et al. (1958). Concentration of penicillin in the serum following intramuscular administration of benzathine penicillin G to children with inactive rheumatic fever. Pediatrics, 67, 387Google Scholar
  9. 9.
    Stollerman, G. H. et al (1955). Prophylaxis against group A streptococci in rheumatic fever. The use of a single monthly injection of benzathine penicillin. N. Engl. J. Med., 259, 581Google Scholar
  10. 10.
    Tompkins, D. G. et al. (1972). Long term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation, 45, 543PubMedGoogle Scholar
  11. 11.
    Neutze, J. M. (1984). Rheumatic fever: an unsolved problem in New Zealand. NZ Med. J., 97, 592Google Scholar
  12. 12.
    Stoller, K. P. and Losey, R. (1985). Inadvertent intra-arterial injection of penicillin: an unseen danger. Pediatrics, 75, 785PubMedGoogle Scholar
  13. 13.
    Krugman, S. and Powell, V. E. (1956). Local tolerance to penicillin: a comparison of five intramuscular preparations. J. Pediatr., 49, 699PubMedCrossRefGoogle Scholar
  14. 14.
    Sprunt, K. et al. (1968). Penicillin resistant alpha streptococci in the pharynx of patients given oral penicillin. Pediatrics, 42, 957PubMedGoogle Scholar
  15. 15.
    Doyle, E. F. et al. (1967). The risk of bacterial endocarditis during anti-rheumatic prophylaxis. J. Am. Med. Assoc., 201, 807CrossRefGoogle Scholar
  16. 16.
    Majeed, H. A. et al. (1984). Recurrences of acute rheumatic fever: a prospective study of 79 episodes. Am. J. Dis. Child., 138, 341PubMedGoogle Scholar
  17. 17.
    Fadahuni, H. O. (1981). Rheumatic fever in Nigerian children: a prospective study. Ann. Trop. Paediatr., 1, 115Google Scholar
  18. 18.
    Bravo, L. C. et al. (1979). Streptococcal infections and rheumatic recurrences in subjects on secondary prophylaxis. Philippine J. Int. Med., 17, 12Google Scholar
  19. 19.
    Peter, G. and Dudley, M. N. (1985). Clinical pharmacology of benzathine penicillin G. Pediatr. Infect. Dis., 4, 586PubMedCrossRefGoogle Scholar
  20. 20.
    Strannegard, I. L. et al. (1987). Antibodies to penicillin in children receiving long-term secondary prophylaxis for rheumatic fever. Allergy, 42, 502PubMedCrossRefGoogle Scholar
  21. 21.
    Schneider, W. F. et al. (1964). Prevention of streptococcal pharyngitis among military personnel and their dependents by mass prophylaxis. JV. Engl. J. Med. 270, 1205CrossRefGoogle Scholar
  22. 22.
    Frank, P. F. et al. (1965). Protection of a military population from rheumatic fever. J. Am. Med. Assoc., 193, 775Google Scholar
  23. 23.
    Rudolph, A. H. and Price, E. V. (1973). Penicillin reactions among patients in venereal disease clinics. J. Am. Med. Assoc., 223, 499CrossRefGoogle Scholar
  24. 24.
    Hsu, I. and Evans, J. M. (1958). Untoward reactions to benzathine penicillin G in a study of rheumatic fever prophylaxis to adults. N. Engl. J. Med., 259, 581PubMedCrossRefGoogle Scholar
  25. 25.
    Steigmann, F. and Suker, J. R. (1962). Fatal reactions to benzathine penicillin G: Report of three cases and discussions of contributing factors. J. Am. Med. Assoc., 179, 288Google Scholar
  26. 26.
    Solley, G. O. et al. (1982). Penicillin allergy: clinical experience with a battery of skin tests. J. Allergy Clin. Immunol., 69, 238PubMedCrossRefGoogle Scholar
  27. 27.
    Erffmeyer, J. E. (1986). Penicillin allergy. Clin. Rev. Allergy, 4, 171PubMedGoogle Scholar
  28. 28.
    Morris, A.J. and Rammelkamp, C. H. (1957). Benzathine penicillin G in the prevention of streptococcal infections. J. Am. Med. Assoc., 165, 664PubMedGoogle Scholar
  29. 29.
    Davis, J. and Schmidt, W. C. (1957). Benzathine penicillin G: Its effectiveness in the prevention of streptococcal infections in a heavily exposed population. N. Engl. J. Med., 256, 339PubMedCrossRefGoogle Scholar
  30. 30.
    Morbidity and Mortality Weekly Report (1988). Acute rheumatic fever at a Navy Training Center, 37, 7Google Scholar
  31. 31.
    Zimmerman, R. A. et al. (1962). An epidemiologic investigation of a streptococcal and rheumatic fever epidemic in Dickensen, North Dakota. Pediatrics, 30, 712Google Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Angelo Taranta
    • 1
    • 2
  • Milton Markowitz
    • 3
  1. 1.New York Medical CollegeNew York CityUSA
  2. 2.Cabrini Medical CenterNew York CityUSA
  3. 3.University of Connecticut School of MedicineFarmingtonUSA

Personalised recommendations